These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35216166)

  • 1. Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob Disease.
    Abu-Rumeileh S; Barschke P; Oeckl P; Baiardi S; Mammana A; Mastrangelo A; Al Shweiki MR; Steinacker P; Ladogana A; Capellari S; Otto M; Parchi P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
    Barschke P; Abu-Rumeileh S; Al Shweiki MHDR; Barba L; Paolini Paoletti F; Oeckl P; Steinacker P; Halbgebauer S; Gaetani L; Lewerenz J; Ludolph AC; Landwehrmeyer GB; Parnetti L; Otto M
    J Neurol; 2022 Sep; 269(9):5136-5143. PubMed ID: 35737109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
    Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
    Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
    Prion; 2013; 7(5):383-93. PubMed ID: 24047819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
    Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
    J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A discriminative event-based model for subtype diagnosis of sporadic Creutzfeldt-Jakob disease using brain MRI.
    Venkatraghavan V; Pascuzzo R; Bron EE; Moscatelli M; Grisoli M; Pickens A; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Klein S; Bizzi A
    Alzheimers Dement; 2023 Aug; 19(8):3261-3271. PubMed ID: 36749840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.
    Schmitz M; Llorens F; Pracht A; Thom T; Correia Â; Zafar S; Ferrer I; Zerr I
    Aging (Albany NY); 2016 Nov; 8(11):2927-2935. PubMed ID: 27852982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
    Gmitterová K; Heinemann U; Krasnianski A; Gawinecka J; Zerr I
    Eur J Neurol; 2016 Jun; 23(6):1126-33. PubMed ID: 27029507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.
    Llorens F; Kruse N; Karch A; Schmitz M; Zafar S; Gotzmann N; Sun T; Köchy S; Knipper T; Cramm M; Golanska E; Sikorska B; Liberski PP; Sánchez-Valle R; Fischer A; Mollenhauer B; Zerr I
    Mol Neurobiol; 2018 Mar; 55(3):2249-2257. PubMed ID: 28321768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
    Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
    Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
    Abu-Rumeileh S; Oeckl P; Baiardi S; Halbgebauer S; Steinacker P; Capellari S; Otto M; Parchi P
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease.
    Pascuzzo R; Oxtoby NP; Young AL; Blevins J; Castelli G; Garbarino S; Cohen ML; Schonberger LB; Gambetti P; Appleby BS; Alexander DC; Bizzi A
    Acta Neuropathol; 2020 Aug; 140(2):169-181. PubMed ID: 32535770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural signature of sporadic Creutzfeldt-Jakob disease.
    Navid J; Day GS; Strain J; Perrin RJ; Bucelli RC; Dincer A; Wisch JK; Soleimani-Meigooni D; Morris JC; Benzinger TLS; Ances BM
    Eur J Neurol; 2019 Aug; 26(8):1037-1043. PubMed ID: 30735286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic Creutzfeldt-Jakob disease and the implication of glycolytic enzymes in prion-induced pathology.
    Gawinecka J; Dieks J; Asif AR; Carimalo J; Heinemann U; Streich JH; Dihazi H; Schulz-Schaeffer W; Zerr I
    J Proteome Res; 2010 Nov; 9(11):5646-57. PubMed ID: 20866111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.
    Tahir W; Zafar S; Llorens F; Arora AS; Thüne K; Schmitz M; Gotzmann N; Kruse N; Mollenhauer B; Torres JM; Andréoletti O; Ferrer I; Zerr I
    Mol Neurobiol; 2018 Jan; 55(1):517-537. PubMed ID: 27975168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.